Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJan 18, 2023Rifampin Capsules USPFailed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.Lupin Pharmaceuticals Inc. · D-0100-2023Class IITerminatedJan 18, 2023Rocuronium Bromide InjectionLack of Assurance of SterilityNephron Sterile Compounding Center LLC · D-0099-2023Class IITerminatedJan 18, 2023Rifampin CapsulesFailed Impurities/Degradation specificationsRemedyRepack Inc. · D-0098-2023Class IITerminatedJan 11, 2023Epi-CaineCGMP Deviations: Raw material recalled by repackager, due to discoloration.Pine Pharmaceuticals, LLC · D-0130-2023Class IICompletedJan 11, 2023Heparin Sodium 2Lack of assurance of sterility: Bags have the potential to leak.Pfizer Inc. · D-0097-2023Class IIITerminatedJan 11, 2023Prochlorperazine Maleate TabletsSubpotent Drug: Out of specification for assay at the 18-month stability timepoint.Jubilant Cadista Pharmaceuticals, Inc. · D-0096-2023Class IIOngoingJan 11, 2023Acyclovir Sodium Injection 1Presence of Particulate Matter: Customer complaint of dark particles found inside the vialEugia US LLC · D-0095-2023Class IIITerminatedJan 4, 2023Timolol Maleate Ophthalmic SolutionFailed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.Apotex Corp. · D-0093-2023Class IICompletedJan 4, 2023Alcohol Antiseptic 80% Topical Solution Hand SanitizerCGMP Deviations: Impurities of acetal and acetaldehyde were discovered in the product in excess of allowed limits.NCH Life Sciences LLC · D-0092-2023Class IICompletedJan 4, 2023Glycopyrrolate TabletsFailed impurities/degradation specifications: Out of specification for unknown impurities.Avkare LLC · D-0091-2023Class IITerminatedJan 4, 2023Ganciclovir for InjectionLabeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.Hikma Pharmaceuticals USA Inc. · D-0090-2023Class IITerminatedDec 28, 2022Quinapril Tablets USPCGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.Lupin Pharmaceuticals Inc. · D-0089-2023Class IITerminatedDec 28, 2022Quinapril Tablets USPCGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.Lupin Pharmaceuticals Inc. · D-0088-2023Class IIOngoingDec 28, 2022Glycopyrrolate TabletsFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-0087-2023Class IITerminatedDec 28, 2022Oxcarbazepine Tablets 600mgPresence of foreign substanceSun Pharmaceutical Industries Inc · D-0085-2023Class IIITerminatedDec 21, 2022Lacosamide Oral SolutionFailed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid contentCamber Pharmaceuticals, Inc · D-0094-2023Class ITerminatedDec 21, 2022IohexolLabeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mLBayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy · D-0086-2023Class IITerminatedDec 21, 2022MenastilcGMP DeviationsAtlantic Management Resources Ltd. · D-0084-2023Class IITerminatedDec 21, 2022ProSironacGMP DeviationsAtlantic Management Resources Ltd. · D-0083-2023Class IITerminatedDec 21, 2022NeuroquellcGMP DeviationsAtlantic Management Resources Ltd. · D-0082-2023Class IITerminatedDec 21, 2022Neuroquell PluscGMP DeviationsAtlantic Management Resources Ltd. · D-0081-2023Class ITerminatedDec 21, 20228.4% Sodium Bicarbonate InjectionDefective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.Exela Pharma Sciences LLC · D-0080-2023Class ITerminatedDec 21, 20228.4% Sodium Bicarbonate InjectionDefective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.Exela Pharma Sciences LLC · D-0079-2023Class IITerminatedDec 21, 2022FentaNYL Citrate 2.5 mg/50 mLUnderfilled units.OurPharma LLC · D-0078-2023Class IITerminatedDec 14, 2022Desmopressin Acetate TabletSubpotent Drug: repackaged product was recalled by the manufacturer for subpotency.RemedyRepack Inc. · D-0077-2023Class IITerminatedDec 14, 20220.9% Sodium Chloride Injection USP 1000 mL Single-dose containerLack of sterility assurance: Bags have the potential to leak.B. Braun Medical, Inc. · D-0076-2023Class IIOngoingDec 14, 20220.9% Sodium Chloride InjectionLack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.Fresenius Medical Care Holdings, Inc. · D-0075-2023Class IIITerminatedDec 7, 2022Sodium Sulfacetamide 10% Sulfur 4% Cleansing PadsSubpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.Acella Pharmaceuticals, LLC · D-0074-2023Class IIITerminatedDec 7, 2022Allergy Relief DFailed dissolution specificationsDr. Reddy's Laboratories, Inc. · D-0073-2023Class IITerminatedDec 7, 2022Desmopressin Acetate Tablets 0.2mgSubpotent DrugHeritage Pharmaceuticals Inc · D-0072-2023Class IIOngoingDec 7, 2022DaytranaDefective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal...Noven Pharmaceuticals Inc · D-0071-2023Class IIITerminatedNov 30, 2022Phenytoin Sodium InjectionLabeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.Acella Pharmaceuticals, LLC · D-0070-2023Class IIITerminatedNov 30, 2022Phenytoin Sodium InjectionLabeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.Acella Pharmaceuticals, LLC · D-0069-2023Class IITerminatedNov 30, 2022Pantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce only...DiscolorationSun Pharmaceutical Industries Inc · D-0068-2023Class IIOngoingNov 23, 2022Adam's Polishes ALCOHOL BASED HAND SANITIZERCGMP Deviations: Other lots of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.Adam's Polishes LLC · D-0067-2023Class IOngoingNov 23, 2022Adam's Polishes ALCOHOL BASED HAND SANITIZERChemical Contamination: FDA analysis found 1 lot of Adam's Polishes ALCOHOL BASED HAND SANITIZER isopropyl alcohol 75% v/v to contain methanol.Adam's Polishes LLC · D-0066-2023Class IITerminatedNov 23, 2022PF-Neostigmine Methylsulfate InjectionCGMP Deviations: Potential for cross contamination due to product carry over.Nephron Sterile Compounding Center LLC · D-0065-2023Class IITerminatedNov 23, 2022PF-Labetalol HCl InjectionCGMP Deviations: Potential for cross contamination due to product carry over.Nephron Sterile Compounding Center LLC · D-0064-2023Class IITerminatedNov 23, 2022Carvedilol TabletsFailed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.Viatris Inc · D-0063-2023Class IIOngoingNov 23, 20220.9% Sodium Chloride InjectionLack of assurance of sterility: Bags have the potential to leak in the flexible containers which may compromise sterility.ICU Medical Inc · D-0062-2023